Amsterdam, Lichtenvoorde, April 17, 2026 – Holland Capital and KinderThuisZorg have entered into a partnership. KinderThuisZorg is a leading provider of specialized pediatric nursing care outside the hospital in the Netherlands.

Tailored and high-quality pediatric care at home

KinderThuisZorg supports approximately 6,500 children and their families each year with appropriate and high-quality care in the child’s familiar environment, at home, at school, or in their immediate surroundings. Through specialized pediatric community nursing teams, care is provided ranging from short-term nursing support to complex and intensive care, such as infusion therapy, tube feeding, and home ventilation. The guiding principle is: the right care in the right place, with the family remaining in control.

Jacqueline Kasten, Managing Director of KinderThuisZorg: “We have found a partner in Holland Capital that shares our vision of providing high-quality care for children and families. This partnership is the result of a carefully managed process and gives us confidence to further develop KinderThuisZorg in the long term.”

Philip Wilms, Investment Director at Holland Capital: “KinderThuisZorg is a strong and distinctive player with an important role in pediatric care in the Netherlands. We look forward to contributing to the further development of KinderThuisZorg with our knowledge, experience, and network in the healthcare sector.”

About KinderThuisZorg

KinderThuisZorg is the largest provider of specialized pediatric nursing care outside the hospital in the Netherlands. The organization supports approximately 6,500 children and their families each year and collaborates nationwide with hospitals, health insurers, and care offices.
KinderThuisZorg has a nationwide network and plays an important role in training pediatric nurses. Through its scale and expertise, the organization contributes to the further development and accessibility of pediatric care in the home setting./medexs.com/

About Holland Capital

For over 40 years, Holland Capital has invested in promising SMEs with growth ambitions in the Benelux and Germany. The firm works closely with management teams to achieve sustainable growth and focuses through specialized sector teams on Healthcare and Technology. Holland Capital has offices in Amsterdam and Düsseldorf. The Dutch Healthcare Authority (NZa) has granted approval for the partnership between Holland Capital and KinderThuisZorg.

Amsterdam, Ede/Rhenen, March 25, 2026 – Our portfolio company Medexs/Van Vliet Healthcare Group, a provider of comprehensive solutions for the medical sector, is acquiring Laméris, a specialist in medical solutions for eye clinics. Through this partnership, medical professionals in ophthalmology and ENT (ear, nose, and throat) can now rely on a single point of contact for the entire chain: from initial construction drawings and the realization of medical spaces to the supply of high-quality equipment and medical consumables.

Laméris has traditionally been known as a comprehensive supplier of medical products, such as diagnostic equipment, surgical instruments, and consumables for ophthalmology. The collaboration with Medexs adds an essential discipline: the construction of the clinic itself. Moreover, with Van Vliet Healthcare as part of the group, a comprehensive package of medical capital goods and disposables can be offered.

“With this collaboration, we can now build the facility itself in addition to providing the interior design,” says Gerald Klein Woolthuis, Managing Director at Laméris. “This means we can ensure that the interior design seamlessly aligns with the construction, including the equipment and IT infrastructure.”

Jos Lans, CEO of Medexs: “The combination of Laméris and Medexs’ disciplines leads to a significant optimization of the construction and interior design process. By sharing knowledge at an early stage, we prevent errors upfront. This results in an approach that is not only faster and more efficient, but ultimately also more cost-effective.”

In the modern healthcare sector, sustainability is a crucial theme. Thanks to Medexs’ expertise in modular and circular construction, and its in-depth knowledge of energy-efficient ventilation systems, the collaboration offers direct access to knowledge and solutions for the sustainable development of medical spaces.

About Laméris

Laméris has been a leading partner for medical professionals in ophthalmology and ENT since 1907. As a total supplier, the company offers customized solutions and high-quality products to enhance the quality of patient care.

About Medexs / Van Vliet Healthcare Group

The Medexs/Van Vliet Healthcare Group is a leading partner for the medical sector, combining the strengths of Van Vliet Healthcare and Medexs. With an integrated approach, ranging from the production and distribution of high-quality medical equipment and diagnostic technology to a broad medical wholesale business, the group supports healthcare professionals worldwide. At the same time, Medexs constructs advanced, classified buildings and spaces, such as operating rooms, cleanrooms, and complete hospitals. Through this unique combination of expertise in technology, design, and infrastructure, the Medexs/Van Vliet Healthcare Group offers a complete solution, with quality, innovation, and reliability at the forefront.ps://medexs.com/

About Holland Capital

Holland Capital has been investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The firm works closely with management teams to achieve sustainable growth and focuses on Healthcare and Technology through specialized sector teams. Holland Capital has offices in Amsterdam and Düsseldorf.

Amsterdam, Zwolle, March 19, 2026 – Software company Sibi has secured an investment from Holland Capital and regional development agency Oost NL. With this financial boost, the company aims to further develop and scale its software to help healthcare organizations better support and retain their employees.

Demographic pressure calls for new solutions

Due to double ageing, the demand for healthcare is rising rapidly, while the number of healthcare professionals is under increasing pressure. According to figures from Statistics Netherlands (CBS), the Netherlands now has more people aged 65 and over than individuals under the age of 20. By 2040, the share of the working-age population (approximately 20–67 years) is expected to decline to around 55–60% of the total population, while the number of elderly continues to grow. For the healthcare sector, this translates into structural staff shortages, increased workload, and growing complexity of care. Technology can help, but only if it aligns with the needs of those delivering care on a daily basis.

The employee as capital in healthcare

While many healthcare innovations focus on patients or care processes, Sibi takes a different approach: placing the employee at the center of the healthcare system. Sibi develops software that supports healthcare organizations throughout the entire employee journey, from onboarding and social intranet to employee engagement surveys and offboarding.

Lennard Veldwijk, founder and owner of Sibi:“Our mission is for healthcare professionals to experience job satisfaction, so that healthcare in the Netherlands remains accessible to everyone. By providing the right attention at the right moments, we strengthen the position of employees and contribute to their sense of ownership, autonomy, and job satisfaction. This is not a ‘soft’ topic, but the foundation of sustainable healthcare.”

Aligned with healthcare transitions

Sibi’s software responds to broader transitions in healthcare, such as the growth of informal care, where family caregivers and volunteers play an increasingly important role. Adoption is also critical in the implementation of healthcare technology: new systems often fail not technically, but in usage. By integrating onboarding, training, and feedback into one platform, Sibi increases the adoption of digital healthcare solutions.

In addition, the platform contributes to sustainable employability. By continuously providing insights into employee experience and engagement, organizations can take timely action, reduce absenteeism, and retain talent. Team leaders are supported with data-driven insights and predictive models that help identify absenteeism and turnover at an early stage.

Investment to accelerate growth

With the investment from Holland Capital and Oost NL, Sibi will further develop its platform and expand its reach among healthcare organizations. Veldwijk: “For Sibi, this investment primarily means the opportunity to accelerate the realization of our mission.”

Sterre Witteveen, Investment Manager Holland Capital “Sibi speelt in op een van de grootste uitdagingen in de zorg: het ondersteunen en behouden van zorgprofessionals. Door de medewerker centraal te stellen, levert het bedrijf een belangrijke bijdrage aan toekomstbestendige zorg.”

About Sibi

Sibi, based in Zwolle, develops software for healthcare organizations that supports the entire employee journey, from onboarding to offboarding. The platform helps organizations better support their employees, increase engagement, and improve sustainable employability.

About Holland Capital

Holland Capital has been investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The firm works closely with management teams to achieve sustainable growth and focuses on Healthcare and Technology through specialized sector teams. Holland Capital has offices in Amsterdam and Düsseldorf.

Düsseldorf (DE) / Ahrensburg (DE) / Oosterhout (NL) / Ahmedabad (IN) – March 17th, 2026 – When a newspaper press stops mid-run or a parcel sorter goes down during peak season, every minute of downtime translates directly into lost revenue. The EAE Group (EAE), consisting of the companies EAE, Q.I. Press Controls and EAE Solutions, develops mission-critical software, vision and control systems that keep these complex industrial environments running. Holland Capital is investing in EAE as a platform to build a leading international group in industrial automation, marking the start of an ambitious growth strategy led by Holland Capital’s dedicated DACH team.

Mission-critical expertise with a 64-year heritage

Founded 64 years ago in Ahrensburg, Germany, EAE established itself as the global leader in automation for web offset printing presses, developing software, camera and control systems that keep the world’s largest newspaper and magazine groups running. Its solutions are deeply embedded in production environments where reliability is everything and downtime is simply not an option. A key differentiator is EAE’s highly advanced software solutions, supported by its retrofit capability. This enables customers to modernise existing installations through software, controls and camera system upgrades, lowering investment thresholds while delivering significant performance gains.

In addition, EAE identified similar demands in the intralogistics market and expanded into delivering turnkey, high-capacity sorting systems, integrating in-house developed software and controls, and mechanical infrastructure into a single, end-to-end solution. Today, its technology forms the intelligent backbone of leading sorting centers, supporting a global client base.

A market at an inflection point 

The investment comes at a pivotal moment for both of EAE’s end markets. In the graphics sector, a large installed base of aging printing presses creates significant upgrade potential. At the same time, sustained e-commerce growth is driving continued expansion of sorting capacity world-wide. In both markets, performance improvements increasingly depends on upgrading the intelligence layer, software, controls and vision systems.

Building a global platform 

Together with Holland Capital as an active strategic partner, EAE will accelerate its growth by investing in innovation, expanding its footprint and pursuing targeted acquisitions worldwide.

Tom van Holten, Managing Director, EAE: “This partnership with Holland Capital enables us to accelerate our growth ambitions and further strengthen our position as a trusted automation partner globally.”

Laurens Platteeuw, Investment Director and Head of DACH at Holland Capital: “EAE combines German engineering excellence with modern software capability in truly mission-critical environments. With growing demand for intelligent upgrades in both intralogistics and printing, we see a clear opportunity to build a leading international automation platform from this strong foundation.”

 New leadership 

As part of this new phase, founders Erik van Holten and Menno Jansen will step back from day-to-day operations. Tom van Holten, who brings more than ten years of experience in the intralogistics sector, will assume the role of Group CEO. 

Supported by an experienced management team, he will lead the company’s strategic and operational development going forward. The founders will remain closely involved as shareholders and strategic advisers, ensuring that their extensive market knowledge and technical expertise remain firmly embedded within the organisation and continue to support its long-term growth. 

About EAE

EAE is an international provider of software, camera and control systems for web offset printing presses and a global integrator with advanced software solutions for the intralogistics market. The company serves a customer base that includes leading printing groups and logistics operators globally. To supports its customers, EAE holds offices in Germany, the Netherlands, India, Spain, and the United States, and is furthermore supported by a network of agencies and service partners. Drawing on decades of engineering expertise, EAE delivers mission-critical automation solutions that enhance operational efficiency, reliability, and performance for its customers around the world.

About Holland Capital

Holland Capital is an independent private equity firm with over 40 years of experience investing in promising Benelux and German SMEs with growth ambitions. The firm focuses on companies with strong market positions and international potential, with dedicated sector teams in Healthcare and Technology. Holland Capital actively pursues platform and buy-and-build investments across Germany and the Netherlands. The investment in EAE marks the seventh transaction executed by the Düsseldorf-based DACH team. Holland Capital has offices in Amsterdam and Düsseldorf and works closely with management teams to realize sustainable long-term growth.

Amsterdam – March 12th, 2026 – Holland Capital has invested in HuisartsenHulp and CareAbout, both specialists in workforce solutions for primary care. The combination creates an organisation that broadly supports general practitioner practices, GP out-of-hours services, pharmacies and other primary care providers with both temporary and structural staffing needs and supporting services.

Rising structural demand for primary care

Demand for primary care in the Netherlands continues to rise due to demographic developments, the decentralisation of healthcare, and increasing healthcare needs. At the same time, the healthcare labour market remains under significant pressure.

HuisartsenHulp and CareAbout respond to this by supporting healthcare providers quickly, effectively and with high-quality solutions to address capacity constraints. The combined organisation thereby contributes to maintaining continuity of care. HuisartsenHulp primarily focuses on safeguarding continuity within GP practices and healthcare centres through its proprietary software platform, while CareAbout specialises in long-term staffing solutions for, among others, pharmacies and GP practices. Together, they offer complementary services with nationwide coverage across primary care.

Joining forces 

By bringing together HuisartsenHulp and CareAbout, a combined organisation is created that focuses on providing flexible, long-term and supportive solutions within primary care. The complementary nature of their target groups, services and networks creates a nationwide platform that supports GP practices and pharmacies in addressing both temporary and structural capacity challenges.

Hans Pruis, CEO of HuisartsenHulp: “With the support of Holland Capital and the collaboration with CareAbout, we can further professionalise and scale our services to better support healthcare providers in a challenging labour market.”

Timothy Hoolhorst, CEO of CareAbout: “This collaboration enables us to further strengthen our expertise and expand our services for both healthcare professionals and clients.”

Philip Wilms, Investment Director at Holland Capital: “The combination of HuisartsenHulp and CareAbout fits well with our investment strategy and sits at the intersection of our focus areas Technology and Healthcare. The combined organisation contributes structurally to the continuity of care in the Netherlands by not merely shifting scarcity, but by adding new capacity.”

About HuisartsenHulp

HuisartsenHulp is a specialised intermediary in primary care and supports GP practices, healthcare centres and GP out-of-hours services with temporary and structural staffing solutions. The organisation has a nationwide network of healthcare professionals and enables rapid deployment to address urgent capacity challenges. In addition, HuisartsenHulp operates its own digital platform that efficiently matches supply and demand and further optimises the deployment of healthcare professionals within primary care.

About CareAbout

CareAbout operates in general practice and pharmacy care, connecting healthcare professionals with GP practices and pharmacies. The organisation offers various contract models, including secondment, flexible contracts and self-employed arrangements, and focuses on sustainable matches and career guidance.

About Holland Capital

Holland Capital has been responsibly and successfully  investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector. 

Amsterdam, Doetinchem, 11th of March 2026 –  Holland Capital invests in Pluggerz, a market leader in custom-made hearing protection. Through this partnership, Pluggerz will be able to further strengthen its position and respond to the structurally increasing demand for hearing protection solutions.

Regulation and prevention awareness drive structural market growth

The market for hearing protection is growing, driven by stricter regulations regarding workplace noise exposure and the increasing responsibility of employers to actively prevent hearing damage. At the same time, societal awareness around hearing loss is increasing. Younger generations in particular are increasingly choosing structural protection.

Custom-made hearing protection

Pluggerz has been the hearing protection specialist of the Netherlands for 40 years and is the market leader in custom-made hearing protection. In addition, the company produces universal  hearing protection and components for hearing aids. The organization combines high-quality customized products with advanced 3D printing technology, in-house R&D, and close collaboration with audiologists for personal fitting.

Investment for growth

The investment by Holland Capital enables Pluggerz to solidify its positions as market leader and invest strategically to fully benefit from the growing demand for hearing protection products.

Hubert Verbeek, Managing Partner Holland Capital: “We look forward to supporting Pluggerz in its development and contributing to the broader adoption of hearing protection. With our Healthcare and Technology expertise, we can help Pluggerz realize commercial acceleration and sustainable value creation.”

About Pluggerz

Pluggerz employs more than 90 people and operates from Doetinchem, where production and office activities take place under one roof. From its own production facilities, the company delivers quickly and efficiently to customers both domestically and internationally. Pluggerz develops and produces components for hearing aids and universal hearing protection for audiology, retail, and industrial clients. In addition, the organization collaborates with a social workshop and actively contributes to inclusive and sustainable employment in the region.

About Holland Capital

For more than 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the shared goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare and Technology sectors. The firm understands the dynamics and opportunities in these sectors and has an extensive network.

Amsterdam, Naarden, 26th of February 2026 –  Our portfolio company Emixa strengthens leadership with new CEO Jan Kritz and COO Peter-Jan Simons to amplify client value and further accelerate growth.

Emixa today announced the appointment of Jan Kritz as its Chief Executive Officer (CEO), reinforcing its commitment to strengthening integrated solutions and enhancing operational execution. Former CEO, Peter-Jan Simons will continue his involvement with Emixa in the role of Chief Operating Officer (COO). This leadership transition ensures that Emixa has the focus and capacity required to sustain long-term growth while continuing to deliver high value outcomes for clients across all markets.

The client is at the heart of Emixa’s strategy 

As the company continues to expand through its strategic buy-and-build approach, strengthening its identity as one unified brand and a truly client-centric organisation is a key priority. Going forward, Emixa will focus on delivering integrated, future-oriented end-to-end solutions that support clients’ digital transformation.

Emixa enters a new phase with a strengthened leadership team

With this new leadership setup, Emixa combines the knowledge and heritage of Emixa with the vision and experience required for the next phase of growth. This structure reflects the phase Emixa is in: scaling its integrated propositions, strengthening regional collaboration, and supporting clients through increasingly complex digital transformation journeys, while continuing to grow in a controlled and sustainable manner.

Peter-Jan Simons, COO of Emixa commented: “We are delighted to welcome Jan Kritz as our CEO. His experience in scaling businesses and leading growing organisations makes him an excellent fit for this next stage of growth. I am excited to continue developing our organisation and to drive our transformation in my new role as COO.”

Jan Kritz, CEO of Emixa mentioned: “I very much look forward to working with our teams to accelerate our strategy. I am especially impressed by the deep passion of our colleagues at Emixa and by their strong dedication to deliver value for our clients”.

About Emixa

Emixa offers its clients innovative, high-quality, end-to-end solutions in digital transformation in amongst others manufacturing, commerce, logistics, construction and infrastructure. Core platforms for digital transformation Siemens (PLM) and SAP (ERP) are complemented by Management Consulting, System Integration, Low-code development and Data & Analytics to serve international clients across the Benelux, DACH, UK & Ireland and Nordics regions. Founded in 2021 through the combination of leading digital consultancies and supported by Holland Capital, Emixa today employs over 550 professionals across Europe.

About Holland Capital

Holland Capital has been responsibly and successfully  investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector. The company has been actively supporting Emixa in its operational and strategic development since joining as a shareholder in 2021.

Amsterdam, December 22nd 2025 – Our portfolio company Adjust Consulting (Adjust) is expanding its advisory proposition with the acquisition of Accent Advies. This transaction strengthens Adjust’s position in control, risk management and audit, and further reinforces its presence in the semi-public sector and the housing corporation sector.

Guido Winnink, CEO of Adjust: “The acquisition of Accent Advies is a valuable addition to our service offering in a domain and sector where we already have a strong position. The expertise, experience and capabilities of Accent Advies will enable us to support our clients even better in addressing complex challenges in control, risk management and audit.”

Marc Breij, on behalf of Accent Advies: “By joining Adjust, we can offer our clients a broader and more comprehensive range of services. At the same time, we become part of a growing organization, allowing us to further strengthen our organization together, for the benefit of our clients and our own development.”

Since becoming a shareholder in 2024, Holland Capital has actively supported Adjust in its operational and strategic development. The collaboration with Accent Advies aligns with Adjust’s buy-and-build strategy.

About Accent Advies

Accent Advies is a specialized advisory firm focusing on integrated risk management, governance, internal audit, process optimization, and strengthening organizational and governance models. The firm is led by Marc Breij, Frank van Egeraat and Sander Boelen, and works with a team of associates.

About Adjust

Founded in 2003, Adjust is a leading advisory firm in the Netherlands specializing in procurement and contract management. At Adjust, people and clients come first: consultants work with passion, integrity and dedication, always striving to balance commercial success with societal impact. Adjust has won the FD Gazellen Award ten times and has been included in the Top 250 Growth Companies by the Erasmus Centre for Entrepreneurship for two consecutive years.

About Holland Capital

Holland Capital has been responsibly and successfully investing in promising Benelux and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare and Technology sectors. They understand the dynamics and opportunities and have an extensive network in these sectors.

Naarden, Stockholm – November 24th, 2025 – Our portfolio company Emixa, a leading European digital transformation consultancy and trusted partner for Siemens, SAP, Mendix and integration technologies, today announced the acquisition of Nextage Group, one of the most respected Siemens Digital Industries Software partners in the Nordic region. This strategic move marks a significant milestone in Emixa’s European expansion and establishes a strong Nordic hub to support manufacturers across Sweden, Finland, Denmark, and the wider region.

A transformational step for Nordic manufacturers
This acquisition establishes a stronger Nordic operations base under the Emixa brand, enabling full support for the digital transformation lifecycle of both regional and international manufacturing customers.

Support from Siemens
Zandra Nilsson, Vice President & Managing Director Nordic Operation at Siemens Digital Industries Software: “I am truly pleased to see Nextage become part of Emixa. Both organisations have consistently shown strong commitment to customer success, technical excellence, and a deep understanding of the Nordic manufacturing landscape. With Emixa’s scale and Nextage’s proven local presence, this new combined team will accelerate the digital transformation of Nordic industry with Siemens technology as a foundation. I look forward to working closely with the expanded Emixa Nordics team.”

Strengthening Emixa’s European footprint

This acquisition supports Emixa’s strategic vision to create Europe’s leading consultancy for Digital Thread and digital transformation. With strong positions already in the Benelux, DACH, and UK&I regions, Emixa now adds a fully operational presence in the Nordics,a region known for innovation and advanced manufacturing.

Peter-Jan Simons, CEO of Emixa, commented: “This acquisition marks a new chapter for Emixa. Nextage brings deep industry knowledge and strong, trusted customer relationships. By onboarding Nextage, we are creating a Nordic powerhouse that combines local expertise with international scale. Most importantly, we are welcoming new colleagues whose talent and commitment will strengthen our shared vision. Together, we are ready to assist Nordic manufacturers accelerate their digital future”.

Tapio Juurakko, CEO, founder and owner of Nextage Group, added: “Joining Emixa is an exciting next stage for Nextage and our clients. We have built a solid foundation in the Nordics, and with Emixa’s complementary technology portfolio and international experience, we can provide even more value and capability to our customers. We are proud to become part of the Emixa family.”

About Nextage

Nextage Group is a Nordic consultancy and Siemens Digital Industries Software partner, focused on supporting manufacturers in their digital transformation journeys. With a strong track record in Product Lifecycle Management (PLM), engineering solutions, and digital innovation, Nextage helps its clients improve product development, efficiency, and competitiveness. With a dedicated team Nextage is serving customers across Sweden, Finland and Denmark.

About Emixa

Emixa offers its clients innovative, high-quality, full-service solutions in digital transformation, with a strong focus on the manufacturing industry and Industry 4.0. Leveraging Siemens, SAP, Mendix, and other leading technologies, Emixa serves international clients across the Benelux, DACH, UK&I, and Nordics regions. Founded in 2021 through the combination of leading digital consultancies and supported by Holland Capital, Emixa today employs over 530 professionals across Europe. This acquisition marks the next step in Emixa’s active buy-and-build strategy. With Nextage joining the group since Holland Capital’s investment, Emixa continues to strengthen its market position, expand its capabilities, and accelerate its international growth trajectory

About Holland Capital

Holland Capital has been responsibly and successfully  investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector. The company has been actively supporting Emixa in its operational and strategic development since joining as a shareholder in 2021.

Bielefeld (Germany), Amsterdam – October 28th, 2025 – Semalytix, a leader in Agentic AI for pharmaceutical patient intelligence, today announced the successful closing of its €5.7 million growth round. The round was led by Holland Capital, a prominent Dutch venture capital firm focusing on the Technology and Healthcare sectors, with participation from existing investors.

Semalytix addresses a critical need in the pharmaceutical sector. The Life Science industry currently generates approximately 30% of the world’s data, and the ability to transform vast amounts of unstructured patient data from public (social) sources into real-time, actionable insights is paramount. Semalytix’s advanced AI-powered analytics technology, PatientGPT, is designed to meet this challenge directly. Evolving rapidly, the team has expanded its AI data foundation to include 33 million medical publications and 100,000+ clinical trial outcomes, and has forged a new generation of Agentic AI models tailored to support specific Pharma roles with crucial patient experience outcomes at every stage of modern drug development. The company has already demonstrated strong commercial traction with several top-20 pharmaceutical companies.

The new funding will be instrumental in accelerating Semalytix’s growth trajectory. Proceeds will be used to further enhance its AI platform’s capabilities, expand its international footprint, particularly in Europe and the USA, strengthen its management and commercial teams, and scale its operational capacity to meet growing customer demand.

“This growth funding is a significant milestone for Semalytix and validates our vision to revolutionise how patient insights are generated and utilised in the pharmaceutical industry,” said Janik Jaskolski, MSc, Co-Founder and CEO of Semalytix. “We are thrilled to welcome Holland Capital as our new partner. Their deep expertise in scaling technology and healthcare companies, demonstrated by their proven track record, including the recent successful exit of HealthConnected to Visma, combined with their strong network, will be invaluable as we enter our next phase of accelerated growth. We are also grateful for the continued trust and support from our existing investors.”

Jan-Frens van Giessel, Partner Healthcare at Holland Capital, commented: “Semalytix addresses a clear and growing need in the Pharma market with its unique AI technology capable of delivering scalable, real-time patient insights. We are impressed by the company’s strong commercial traction, highly defensible technology, and the ambitious vision of the founding team. Holland Capital is excited to partner with Semalytix and leverage our experience to support their journey in becoming a global leader in AI-powered patient intelligence.”

About Semalytix GmbH

Based in Bielefeld, Germany, Semalytix GmbH provides an Agentic AI platform for the pharmaceutical industry. Its PatientGPT-powered Atlas platform enables Pharma teams to compliantly access the global patient voice and, increasingly, to build, deploy, and own a library of custom AI models. This “Agent-as-a-Service” model allows companies to embed patient intelligence directly into their workflows, a critical capability given that 75-85% of pharmaceutical workflows are estimated to contain tasks that can be automated or augmented by AI agents. This model allows companies to build compounding intellectual property, moving beyond disposable research to create durable strategic assets.

About Holland Capital

Holland Capital has been responsibly and successfully  investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector.